AnticipatedClinical trial: Optional / allowed
TSC Alliance Early-Stage Investigator Research Grant
TSC Alliance · Nonprofit
Source: TSC Alliance (curated) · View original posting ↗
Annual cycle — the 2026 LOI closed May 18, 2026; next round not yet posted.
- AwardWhat a single award can be worth — the funder's published per-award amount or floor–ceiling range.
- Up to $150K
- DeadlineFinal application due date.
- Not yet posted
- Letter of intentDue date for the letter of intent (a short pre-application some funders require or request before the full proposal).
- —
- MechanismNIH activity code — the grant type (R01 research project, R21 exploratory, K series career development, F series fellowship, …).
- —
- DurationMaximum project period for a single award.
- 2 yr
- Expected awardsHow many awards the funder anticipates making under this opportunity.
- —
- Funding cycleHow often the program accepts applications (annual, multiple cycles per year, rolling, or one-time).
- Recurring (annual)
- Open dateWhen applications open (or opened).
- —
- Total fundingThe overall pool the funder expects to commit across ALL awards under this opportunity — not what one project receives.
- $150K total
- Clinical trialWhether proposed projects must, may, or must not include a clinical trial.
- Optional / allowed
Early careerHigher educationNonprofit
Research areas
Basic mechanisms & biologyBiomarkers & diagnosticsTherapeutics & drug discoveryTraining & career development
Auto-classified from the title and description (keyword-based) — may be imperfect.
Description
$75,000/year (including indirect) for up to two years for early-career independent researchers driving innovative tuberous sclerosis complex research; co-funded with the Wong Family Foundation. Postdoctoral fellowships are also offered. Curated entry; verify current terms at the program page.
This funder has no public API, so the entry is manually curated — confirm current amounts, deadlines, and eligibility on the source page.